SAM
MRTX

Stenahm Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Stenahm Asset Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-19,300
Closed -$3.41M – 25
2021
Q3 		$3.41M Hold
19,300
– – 2.23% 19
2021
Q2 		$3.12M Buy
+19,300
New +$3.12M 1.91% 20